PHAL
Spotlight Stock Market
Biotechnology & Pharmaceuticals
Health Care
PharmaLundensis is a research company. The company's main focus is on the treatment of serious lung diseases. Diseases that the company specializes in include chronic obstructive pulmonary disease (COPD), chronic bronchitis, and influenza-induced pulmonary failure. In addition to its main business, technical systems for handling drug emissions are developed. PharmaLundensis has its headquarters in Lund.
Read moreEPS (adj.)
Dividend %
General meeting '26
Interim report Q2'26
Interim report Q3'26
Don't miss out - create an account and get all the possible benefits